These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12877389)

  • 21. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer.
    Varella-Garcia M; Akduman B; Sunpaweravong P; Di Maria MV; Crawford ED
    Urol Oncol; 2004; 22(1):16-9. PubMed ID: 14969798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
    Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FISHing and beyond in urinary cytology.
    Dahmoush L; Cohen MB
    Diagn Cytopathol; 2004 Oct; 31(4):201. PubMed ID: 15386797
    [No Abstract]   [Full Text] [Related]  

  • 25. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer.
    Song MJ; Lee HM; Kim SH
    Cancer Genet Cytogenet; 2010 Apr; 198(2):144-50. PubMed ID: 20362229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiprobe FISH for enhanced prediction of recurrent bladder cancer].
    Zellweger T; Benz G; Herzog M; Grilli B; Mihatsch MJ; Gasser TC; Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():194-8. PubMed ID: 16892552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.
    Bubendorf L; Piaton E
    Ann Pathol; 2012 Dec; 32(6):e52-6, 438-43. PubMed ID: 23244486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
    Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP
    Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing.
    Hajdinjak T
    Urol Oncol; 2008; 26(6):646-51. PubMed ID: 18367109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract.
    Sassa N; Iwata H; Kato M; Murase Y; Seko S; Nishikimi T; Hattori R; Gotoh M; Tsuzuki T
    Am J Clin Pathol; 2019 Apr; 151(5):469-478. PubMed ID: 30668617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
    Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
    BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
    Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
    Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.
    García-Peláez B; Trias I; Román R; Pubill C; Banús JM; Puig X
    Actas Urol Esp; 2013; 37(7):395-400. PubMed ID: 23453297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reflex UroVysion testing in suspicious urine cytology cases.
    Ferra S; Denley R; Herr H; Dalbagni G; Jhanwar S; Lin O
    Cancer; 2009 Feb; 117(1):7-14. PubMed ID: 19347824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria.
    Pajor G; Somogyi L; Melegh B; Alpar D; Kajtar B; Farkas L; Kneif M; Bollmann D; Pajor L; Sule N
    Cytometry A; 2011 May; 79(5):375-82. PubMed ID: 21465665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].
    Bao QB; Liu J; Sun HB; Su JH; Zhu JG; Lin JZ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):548-51. PubMed ID: 19567078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.